
The antiviral pill Paxlovid not only reduces hospitalization and death after catching COVID-19: New research shows it also cuts the chances of long COVID by roughly 25%. The drug, which combines a newer antiviral called nirmatrelvir with an older medication known as ritonavir, delivered that added bonus to patients, at least the mostly older white… read on > read on >